BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17351474)

  • 21. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
    Chung LP; Waterer G; Thompson PJ
    Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited beta2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics.
    van Veen A; Wierenga EA; Westland R; Weller FR; Hart GA; Jansen HM; Jonkers RE
    Respir Res; 2006 Jan; 7(1):19. PubMed ID: 16448568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with inhaled corticosteroids improves pulmonary function in children under 2 years old with risk factors for asthma.
    Teper AM; Kofman CD
    Curr Opin Allergy Clin Immunol; 2006 Jun; 6(3):152-4. PubMed ID: 16670505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.
    Tantisira KG; Lake S; Silverman ES; Palmer LJ; Lazarus R; Silverman EK; Liggett SB; Gelfand EW; Rosenwasser LJ; Richter B; Israel E; Wechsler M; Gabriel S; Altshuler D; Lander E; Drazen J; Weiss ST
    Hum Mol Genet; 2004 Jul; 13(13):1353-9. PubMed ID: 15128701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based pharmacologic treatment for mild asthma.
    Koh MS; Irving LB
    Int J Clin Pract; 2007 Aug; 61(8):1375-9. PubMed ID: 17590220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-acting beta-2 agonists in asthma.
    Med Lett Drugs Ther; 2009 Jan; 51(1303):1-2. PubMed ID: 19122566
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?
    Lipworth BJ
    Trends Pharmacol Sci; 2007 Jun; 28(6):257-62. PubMed ID: 17466387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid therapy for asthma in children.
    Spahn JD; Szefler SJ
    Curr Opin Pediatr; 2007 Jun; 19(3):300-5. PubMed ID: 17505190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of beta agonists.
    Donohue JF
    Respir Care; 2008 May; 53(5):618-22; discussion 623-4. PubMed ID: 18426615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease.
    Wang ZL
    Chin Med J (Engl); 2007 Jun; 120(12):1097-105. PubMed ID: 17637229
    [No Abstract]   [Full Text] [Related]  

  • 31. Obstructive lung disease from conception to old age: differences in the treatment of adults and children with asthma.
    O'Byrne PM
    Proc Am Thorac Soc; 2009 Dec; 6(8):720-3. PubMed ID: 20008883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma.
    Hancox RJ; Sears MR; Taylor DR
    Eur Respir J; 1998 Mar; 11(3):589-93. PubMed ID: 9596107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical appraisal of antileukotriene use in asthma management.
    Polosa R
    Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.
    Chu YT; Chiang W; Wang TN; Hung CH; Jong YJ; Wu JR
    J Microbiol Immunol Infect; 2007 Apr; 40(2):162-7. PubMed ID: 17446966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacogenomics of asthma: present and perspective].
    Szalai C; Tölgyesi G; Nagy A; Falus A
    Orv Hetil; 2006 Jan; 147(4):159-69. PubMed ID: 16515024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-2 adrenergic receptor genetic polymorphisms and asthma.
    Hizawa N
    J Clin Pharm Ther; 2009 Dec; 34(6):631-43. PubMed ID: 20175796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The practice guideline 'Asthma in children' (second revision) from the Dutch College of General Practitioners; a response from the perspective of paediatric pulmonology].
    de Jongste JC
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):543-5. PubMed ID: 18402318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "As-required" combination therapy with inhaled corticosteroids and long-acting beta-2 agonists for asthma: current evidence and recommendations.
    Taylor DR; Jayaram L; Asher MI; Epton MJ
    N Z Med J; 2008 Nov; 121(1285):106-18. PubMed ID: 19079443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating combination therapies for asthma: pros, cons, and comparative benefits.
    Bjermer L
    Ther Adv Respir Dis; 2008 Jun; 2(3):149-61. PubMed ID: 19124367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.